The table below shows BIOCRYST PHARMACEUTICALS INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$156.41M
$159.40M
$163.35M
$145.53M
$117.08M
$109.33M
Cost of revenue
$5.38M
$2.19M
$2.80M
$4.57M
$3.21M
$1.70M
Gross profit
-
-
-
-
-
-
R&D
$60.32M
$44.60M
$43.39M
$37.27M
$41.08M
$37.62M
BCRX annual revenue (10-K history)
BIOCRYST PHARMACEUTICALS INC reported annual revenue of $874.84M for fiscal year 2025. That is up 94.1% from $450.71M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $26.35M (FY 2016) to $874.84M. Figures come from the company's audited annual reports as filed with the SEC.
